Newsroom
Sorted by: Latest
-
Franklin Templeton Announces Availability of 19(a) Notices for Certain Closed-End Funds
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--The 19(a) monthly distribution notices for Templeton Emerging Markets Income Fund (NYSE: TEI) are now available. These informational notices provide further details on the sources of the funds’ monthly distributions and follow the most recent distribution announcement. The table below provides an estimate of the sources of the Fund’s current distribution and its cumulative distributions paid this fiscal year-to-date. Amounts are expressed on a per share o...
-
DNP投資Rapidus,支援下一代半導體量產體系建設
東京--(BUSINESS WIRE)--(美國商業資訊)-- Dai Nippon Printing Co., Ltd. (DNP, TOKYO:7912)今日宣布,公司以投資方之一的身分參與了Rapidus Corporation的融資輪。本次策略性融資將支援Rapidus從目前研發階段穩步邁向2027年實現2奈米(10⁻⁹公尺)邏輯半導體量產的計畫。 透過本次融資,DNP將加快極紫外微影光罩的開發和量產,為Rapidus搭建2奈米及下一代半導體量產體系提供支援。 背景 近年來,隨著資料生成量成長帶來的能耗上升已成為一項挑戰,市場對能夠提升裝置效能和降低功耗的下一代半導體需求持續成長。 相較現有技術,採用極紫外微影技術製造的下一代半導體可在矽片上形成更精細的電路圖案。這反過來又提高了人們對實現更高效能、更低功耗半導體的期望。 在此背景下,DNP於2024年在日本新能源產業技術綜合開發機構(NEDO)主導的「後5G資通訊系統基礎設施強化研發專案」中被選定為Rapidus的子承包商。憑藉該專案,DNP持續推進2奈米世代極紫外微影光罩製造製程的開發。 展望未來,為協助Rapidus在20...
-
Citibank UK Regulatory Announcement: FRN Variable Rate Fix
LONDON--(BUSINESS WIRE)-- Re: The Toronto-Dominion Bank (Covered Bonds) EUR 1,000,000,000.00 MATURING: 03-Sep-2027 ISIN: XS2895483787 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 03-Mar-2026 TO 03-Jun-2026 HAS BEEN FIXED AT 2.32 PCT DAY BASIS: ACTUAL/360 INTEREST PAYABLE VALUE 03-Jun-2026 WILL AMOUNT TO: EUR 5,936,555.56 PER EUR 1,000,000,000.00 DENOMINATION ...
-
DNP投资Rapidus,支持下一代半导体量产体系建设
东京--(BUSINESS WIRE)--(美国商业资讯)-- Dai Nippon Printing Co., Ltd. (DNP, TOKYO:7912)今日宣布,公司作为投资方之一参与了Rapidus Corporation的融资轮。本次战略性融资将支持Rapidus从当前研发阶段稳步迈向2027年实现2纳米(10⁻⁹米)逻辑半导体量产的计划。 通过本次融资,DNP将加快极紫外光刻光掩模的开发和量产,为Rapidus搭建2纳米及下一代半导体量产体系提供支持。 背景 近年来,随着数据生成量增长带来的能耗上升已成为一项挑战,市场对能够提升设备性能和降低功耗的下一代半导体需求持续增长。 与现有技术相比,采用极紫外光刻技术制造的下一代半导体可在硅片上形成更精细的电路图案。这反过来又提高了人们对实现更高性能、更低功耗半导体的期望。 在此背景下,DNP于2024年在日本新能源产业技术综合开发机构(NEDO)主导的“后5G信息和通信系统基础设施强化研发项目”中被选定为Rapidus的子承包商。依托该项目,DNP持续推进2纳米世代极紫外光刻光掩模制造工艺的开发。 展望未来,为助力Rapidus在...
-
Bayer Reports Results for the Investigational Targeted Radionuclide Therapy 225Ac-PSMA-Trillium in Advanced Metastatic Prostate Cancer
BERLIN--(BUSINESS WIRE)--Bayer today announced results from the ongoing global Phase I first-in-human, dose-escalation PAnTHa study (NCT06217822) evaluating the safety, tolerability and preliminary efficacy of 225Ac-PSMA-Trillium (BAY 3563254), a next-generation targeted alpha therapy (TAT) in patients with advanced metastatic castration-resistant prostate cancer (mCRPC). The dose for expansion was successfully identified, with ≥80% of patients achieving a PSA50 response at the expansion dose....
-
Median Technologies fera une présentation à la 46ème conférence annuelle Health Care de TD Cowen
SOPHIA ANTIPOLIS, France--(BUSINESS WIRE)--Regulatory News: Median Technologies (FR0011049824, ALMDT, éligible PEA/PME, « Median » ou « La Société »), développeur d’eyonis®, une suite de logiciels dispositifs médicaux basés sur l’intelligence artificielle (IA) pour le diagnostic précoce des cancers, et un leader mondial de la fourniture d’analyses d’images par IA et de services centraux d’imagerie pour les essais cliniques en oncologie de l’industrie biopharmaceutique, annonce sa participation...
-
Median Technologies to present at the TD Cowen 46th Annual Health Care Conference
SOPHIA ANTIPOLIS, France--(BUSINESS WIRE)--Regulatory News: Median Technologies (FR0011049824, ALMDT, “Median” or the “Company”), developer of eyonis®, a suite of artificial intelligence (AI) powered Software as a Medical Device (SaMD) for early cancer diagnosis, and a globally leading provider of AI-based image analyses and central imaging services for oncology drug developers announced today that it will participate in TD Cowen’s 46th Annual Health Care Conference, taking place March 2-4, 202...
-
Macy's, Inc. Board of Directors Announces Increase to Quarterly Dividend
NEW YORK--(BUSINESS WIRE)--Macy’s, Inc. Board of Directors Announces Increase to Quarterly Dividend...
-
Riassunto: HighRadius lancia una soluzione a 0 dollari di costi di implementazione, 0 dollari di costi di iscrizione tramite la strategia di prezzo basato sui risultati per il software oCFO
HOUSTON--(BUSINESS WIRE)--HighRadius lancia il primo sistema di prezzi basati sui risultati per l'ufficio CFO con 0 dollari di costi di implementazione e 0 dollari di costi di iscrizione fino all'attivazione. I clienti pagano solamente una parte dei guadagni ottenuti in base all'impatto sul conto economico. Capitolo 1: Prezzo basato sui risultati (OBP) Presentazione di OBP: HighRadius, fornitore di oltre 190 agenti IA per per order-to-cash, contabilità fornitori, record-to-report e tesoreria, p...
-
Samenvatting: HighRadius lanceert een implementatiekost van $0 en een abonnementskost van $0 via Outcome Based Pricing voor oCFO-software
HOUSTON--(BUSINESS WIRE)--HighRadius lanceeert eerste Outcome Based Pricing voor Office van de CFO met een implementatiekost van $0 en een abonnementskost van $0 tot aan de Go-Live. Klanten betalen enkel een fractie van de gerealiseerde baten op basis van P&L-impact. Hoofstuk 1: OBP (Outcome Based Pricing) Introductie van OBP: HighRadius, een aanbieder van meer dan 190 AI agents voor Order-to-Cash, Accounts Payable, Record-to-Report en Treasury, introduceert OBP (Outcome Based Pricing). Dri...